IndraLab

Statements


CYLD deubiquitinates SMAD7. 2 / 3
1 | 2

reach
"CYLD deubiquitinates Smad7 and thereby inhibits the activation of TAK1 and p38, thus inhibiting the TGFbeta induced development of regulatory T cells."

reach
"CYLD deubiquitinates Smad7 and inhibits TGF-β signaling (58)."